A new clinical trial called PhEAST is testing whether electrical stimulation applied to the throat can help stroke patients recover their ability to swallow. According to Gram Research analysis, the trial involves 638 stroke patients receiving either six days of gentle electrical stimulation or standard care alone. More than 50% of stroke patients develop swallowing problems, and this treatment aims to reorganize the brain’s swallowing control centers to restore normal function and eliminate the need for feeding tubes.
More than half of stroke patients struggle with swallowing, a serious complication that can lead to malnutrition and pneumonia. Researchers are testing a new treatment called pharyngeal electrical stimulation (PES)—gentle electrical pulses applied to the throat—to help restore normal swallowing. According to Gram Research analysis, this international trial involving 638 stroke patients will determine whether six days of this electrical stimulation treatment, combined with standard care, can help patients recover their ability to eat and drink normally. Results could offer hope to thousands of stroke survivors currently dependent on feeding tubes.
Key Statistics
A 2026 randomized controlled trial of 638 stroke patients found that more than 50% of acute ischaemic stroke and intracerebral hemorrhage patients develop swallowing problems requiring feeding tube support.
The PhEAST trial, recruiting from 45 hospitals across the UK and Austria, enrolled 574 participants by mid-2026 to test whether six days of 10-minute daily electrical stimulation sessions improve swallowing recovery compared to standard care alone.
Researchers are measuring swallowing improvement using the dysphagia severity rating scale at 2 weeks and 3 months, with extended follow-up tracking pneumonia rates, feeding tube dependency, and quality of life outcomes through one year post-stroke.
The Quick Take
- What they studied: Whether gentle electrical stimulation applied to the throat can help stroke patients regain their ability to swallow normally
- Who participated: 638 stroke patients from hospitals in the UK and Austria who developed swallowing problems within 2-31 days after their stroke and needed feeding tubes
- Key finding: This is an ongoing trial testing whether 10 minutes daily of electrical stimulation for six days can improve swallowing function compared to standard care alone
- What it means for you: If successful, this treatment could help stroke survivors avoid long-term feeding tubes and reduce serious complications like pneumonia, though results won’t be available until late 2026
The Research Details
The PhEAST trial is a large international study comparing two groups of stroke patients. One group receives six days of pharyngeal electrical stimulation (PES)—a 10-minute daily treatment using gentle electrical pulses on the throat—plus standard care. The other group receives only standard care without the electrical stimulation. Researchers are tracking both groups to see which recovers swallowing function better.
The study uses careful blinding, meaning the doctors measuring results don’t know which patients received the electrical stimulation treatment. This prevents bias from affecting the findings. Patients are being recruited from 45 hospitals across the UK and Austria, making this a truly international effort to find better treatments for stroke-related swallowing problems.
The main measurement is the dysphagia severity rating scale (DSRS), which trained observers use to assess how well patients can swallow. Researchers will measure this at two weeks and three months, then continue tracking patients for a full year to see long-term benefits.
This research design is important because swallowing problems after stroke currently have no proven effective treatment. By comparing electrical stimulation to standard care in a large, carefully controlled study, researchers can determine whether this approach truly works. The year-long follow-up period helps identify both immediate benefits and lasting improvements, which is crucial for understanding whether patients can eventually stop using feeding tubes permanently.
This is a high-quality study design (Phase 4 trial) with several strengths: large sample size of 638 patients, international recruitment from multiple hospitals, blinded outcome assessment to prevent bias, and long-term follow-up tracking. The study follows SPIRIT guidelines, which are international standards for reporting clinical trials. However, as an ongoing trial, final results are not yet available. The open-label design means patients and some staff know who receives the treatment, though this is standard for this type of research.
What the Results Show
This trial is currently ongoing with recruitment expected to complete in October 2026, so final results are not yet available. However, the study has successfully enrolled more than 574 participants from 45 hospitals, demonstrating strong international collaboration and patient interest in finding better treatments for post-stroke swallowing problems.
The primary outcome being measured is the dysphagia severity rating scale (DSRS), which objectively assesses how much swallowing function improves. Researchers will compare this measurement between the electrical stimulation group and the standard care group at two weeks and three months after treatment.
The trial is designed to detect whether electrical stimulation produces meaningful, clinically relevant improvements in swallowing—not just small statistical changes. This practical focus means the results will directly answer whether this treatment actually helps patients return to normal eating and drinking.
Beyond swallowing improvement, researchers are tracking many other important health outcomes. These include whether patients can transition from feeding tubes to eating by mouth, rates of pneumonia (a common complication of swallowing problems), antibiotic use, quality of life, mood, cognitive function, and overall disability. The study also measures health economics—essentially, whether the treatment is cost-effective for healthcare systems. These secondary outcomes paint a complete picture of how electrical stimulation affects overall stroke recovery, not just swallowing alone.
Currently, no definitive treatments exist for post-stroke swallowing problems, making this research particularly important. Previous smaller studies have suggested that electrical stimulation may help reorganize the brain’s swallowing control centers, but large-scale evidence is lacking. This PhEAST trial is designed to provide the rigorous evidence needed to determine whether electrical stimulation should become standard treatment. The international scope and large sample size represent a significant step forward compared to previous smaller studies.
The main limitation is that results are not yet available—this is an ongoing trial. Additionally, the study uses an open-label design, meaning patients and some staff know who receives the electrical stimulation, which could potentially influence how patients perceive their recovery. However, the blinded outcome assessment (where doctors measuring results don’t know treatment assignment) helps minimize this bias. The study is limited to UK and Austrian hospitals, so results may need confirmation in other populations and healthcare settings.
The Bottom Line
This trial is still collecting data, so specific clinical recommendations cannot yet be made. However, stroke patients with swallowing difficulties should discuss all available treatment options with their healthcare team, including participation in clinical trials if eligible. Standard swallowing therapy remains the foundation of care. Once PhEAST results are published in late 2026 or 2027, they may change clinical practice recommendations.
This research is most relevant to stroke patients experiencing swallowing difficulties, their families, and healthcare providers treating post-stroke complications. It’s particularly important for patients dependent on feeding tubes who want to return to normal eating. Neurologists, speech-language pathologists, and stroke specialists should monitor these results closely. General public awareness is valuable because early recognition of swallowing problems after stroke can lead to faster treatment.
The trial is measuring outcomes at 2 weeks, 3 months, 6 months, and 1 year after treatment. If electrical stimulation works, patients might see initial improvements within the first two weeks of treatment. However, the most meaningful recovery typically occurs over the first three months. Full results from this trial are expected in late 2026 or early 2027 after all participants complete follow-up and data analysis is complete.
Frequently Asked Questions
What is pharyngeal electrical stimulation and how does it help stroke patients swallow?
Pharyngeal electrical stimulation uses gentle electrical pulses applied to the throat to stimulate swallowing muscles and help reorganize the brain’s swallowing control centers. This 10-minute daily treatment aims to restore normal swallowing function in stroke patients who’ve lost this ability.
How many stroke patients have swallowing problems after a stroke?
More than 50% of patients who experience acute ischaemic stroke or intracerebral hemorrhage develop swallowing difficulties. These complications can lead to serious health problems like pneumonia and malnutrition if not treated effectively.
When will results from the PhEAST trial be available?
The PhEAST trial is expected to complete recruitment by October 2026, with final results likely available in late 2026 or early 2027 after all participants complete their one-year follow-up assessments and data analysis is finished.
Can stroke patients currently get electrical stimulation treatment for swallowing problems?
Electrical stimulation for swallowing is still experimental and primarily available through clinical trials like PhEAST. Standard swallowing therapy remains the main treatment. Patients should discuss trial participation with their stroke care team if eligible.
What complications can swallowing problems cause after a stroke?
Post-stroke swallowing difficulties can lead to pneumonia, malnutrition, dehydration, and long-term feeding tube dependency. These complications significantly impact quality of life and recovery outcomes, making effective treatment crucial for stroke survivors.
Want to Apply This Research?
- Users recovering from stroke could track daily swallowing function using a simple 1-10 scale (1=cannot swallow safely, 10=normal swallowing), noting any changes in ability to eat different food textures, incidents of coughing while eating, or progress toward removing feeding tubes
- If prescribed electrical stimulation treatment, users should set daily reminders for their 10-minute treatment sessions and log completion in the app. They could also track dietary progression—from tube feeding to soft foods to regular foods—as a tangible measure of recovery
- Establish a weekly review comparing swallowing function scores, dietary intake changes, and any complications like coughing or aspiration. Create a visual progress chart showing movement from tube-dependent to oral feeding, with milestone celebrations at 2-week and 3-month marks
This article describes an ongoing clinical trial and does not constitute medical advice. Swallowing problems after stroke require professional medical evaluation and treatment. Patients should not attempt electrical stimulation or change their swallowing management without consulting their healthcare provider. This research is preliminary and final results are pending. Always discuss treatment options, including clinical trial participation, with your stroke care team. Individual results may vary, and this treatment may not be appropriate for all patients.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.